I agree that this site is using cookies. You can find further informations here.
X
Lavalaye, J.
72  results:
Search for persons X
?
1

Real-world outcomes of first-line chemotherapy for unresect..:

Reesink, Daan J. ; van de Garde, Ewoudt M. W. ; van der Nat, Paul B....
Tijdschrift voor Urologie.  14 (2024)  4 - p. 74-84 , 2024
Link: https://doi.org/10.1007/..
 
?
2

68Ga-PSMA-PET/CT in patients starting on Active Surveillanc..:

Heetman, J.G. ; Lavalaye, J. ; Polm, P.D....
European Urology.  83 (2023)  - p. S1366 , 2023
Link: https://doi.org/10.1016/..
 
?
3

The conundrum of treating metastatic hormone sensitive pros..:

van Elst, T. ; Mehra, N. ; Vis, A.N....
European Urology Open Science.  57 (2023)  - p. S161 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Development and internal validation of nomograms incorporat..:

Heetman, J.G. ; Kelder, H. ; Soeterik, T.F.W...
European Urology.  83 (2023)  - p. S1804 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Is cribriform pattern in prostate biopsy a risk factor for ..:

Heetman, J. G. ; Versteeg, R. ; Wever, L....
World Journal of Urology.  41 (2023)  8 - p. 2165-2171 , 2023
Link: https://doi.org/10.1007/..
 
?
6

The additional value of 68Ga-PSMA PET/CT SUVmax in predicti..:

Heetman, J.G. ; Paulino Pereira, L.J. ; Kelder, J.C....
European Urology Open Science.  57 (2023)  - p. S23-S24 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Correction: Is cribriform pattern in prostate biopsy a risk..:

Heetman, J. G. ; Versteeg, R. ; Wever, L....
World Journal of Urology.  , 2023
Link: https://doi.org/10.1007/..
 
?
8

Real-world outcomes of first-line chemotherapy for unresect..:

Reesink, Daan J. ; van Melick, Harm H. E. ; van der Nat, Paul B....
World Journal of Urology.  41 (2023)  6 - p. 1551-1562 , 2023
Link: https://doi.org/10.1007/..
 
?
9

Is cribriform pattern in biopsy a risk factor for metastati..:

Heetman, J.G. ; Versteeg, R. ; Wever, L.L....
European Urology Open Science.  45 (2022)  - p. S96 , 2022
Link: https://doi.org/10.1016/..
 
?
10

POSC399 Treatment Effect and Costs of the Complete Therapeu..:

Holleman, MS ; Santi, I ; Huygens, S...
Value in Health.  25 (2022)  1 - p. S266-S267 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Hospital variation in treatment patterns and oncological ou..:

Reesink, Daan J. ; van de Garde, Ewoudt M. W. ; van der Nat, Paul...
World Journal of Urology.  40 (2022)  6 - p. 1469-1479 , 2022
Link: https://doi.org/10.1007/..
 
?
12

68Ga-PSMA-PET/CT in newly diagnosed patients on active surv..:

Heetman, J.G. ; Polm, P.D. ; Soeterik, T.F.W....
European Urology Open Science.  33 (2021)  - p. S212 , 2021
Link: https://doi.org/10.1016/..
 
?
13

68Ga-PSMA-PET/CT in newly diagnosed patients on active surv..:

Polm, P.D. ; Lavalaye, J. ; Soeterik, T.F.W....
European Urology.  79 (2021)  - p. S1277 , 2021
Link: https://doi.org/10.1016/..
 
?
14

Optimization of injected 68Ga-PSMA activity based on list-m..:

Wielaard, J. ; Habraken, J. B. A. ; Brinks, P...
EJNMMI Physics.  7 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
15

Validation of Gallium-68 PSMA-PET/CT for primary lymph node..:

Van Kalmthout, L. ; Van Melick, H. ; Lavalaye, J....
European Urology Supplements.  18 (2019)  1 - p. e1945-e1946 , 2019
Link: https://doi.org/10.1016/..
 
1-15